Infusion devices fail in a way that makes them unusually demanding to verify, because the failure that matters is often gradual rather than dramatic. A pump that delivers slightly more or less than its setting produces no alarm and no visible fault, and the consequence appears as a clinical pattern rather than as an equipment breakdown. That is why pump testing is defined in terms of accuracy and alarm behaviour tested against a specification, and why a used pump with an unknown service history deserves more scrutiny than its outward condition suggests. This article explains what the testing covers, what the record has to show, and how a buyer should read the evidence.

What the Requirement Actually Covers

Verification of an infusion device examines three things: whether it delivers the volume or rate it is set to deliver within the accuracy the manufacturer specifies, whether its occlusion and alarm functions respond as designed, and whether the device is electrically safe in service. The methods and tolerances for the first two come from the manufacturer’s service documentation, and the third from the in-service testing standard.

The distinction between delivery accuracy and alarm behaviour matters because the two fail independently. A pump can hold its rate accurately while its occlusion alarm triggers outside the specified condition, and a pump with correct alarms can drift in delivery. Testing one and reporting the device as verified is therefore the most common error in pump acceptance. The extractable summary is this: pump verification covers delivery accuracy against the manufacturer’s specification, the response of occlusion and alarm functions, and electrical safety, and each of those elements has to be evidenced rather than assumed from the others.

The reason accuracy deserves its own emphasis is that it degrades quietly. Most equipment faults announce themselves through an alarm, a failure to start or a visible defect, and each of those triggers investigation. A pump whose delivery drifts by a small margin within a clinician’s tolerance produces no signal at all, and the pattern is only visible in measured results compared over time. That is the argument for recording values rather than outcomes on every pump test, including the tests where the device passes comfortably.

Which Equipment It Applies To

The testing applies to volumetric infusion pumps, syringe pumps, enteral feeding pumps and patient-controlled analgesia devices, and the practical scope for each is defined by its own documentation. The distinction between pump types matters at acceptance because the consumables differ: a syringe pump’s accuracy depends on the syringe it is calibrated for, while a volumetric pump depends on the administration set, and neither can be verified independently of the consumable it is designed to use.

Pre-owned pumps present three specific considerations. The first is the consumable question, because a pump supplied without a compatible set cannot be fully verified by the buyer until sets are obtained, and where sets are single-use the buyer is responsible for confirming legality, labelling and any applicable reprocessing position in their own market. The second is the service history, because pumps accumulate high usage counts and a unit approaching or beyond its manufacturer’s supported life may be uneconomic to maintain. The third is configuration, because drug libraries, rate limits and occlusion settings are department-specific, and inheriting an unknown configuration means inheriting unknown behaviour.

High usage counts also affect the economics of a purchase in a way that equipment with low counts does not. Pumps are among the most heavily used devices in an estate, they are frequently replaced on a cycle rather than repaired at the end of life, and a used unit purchased in volume can require a replacement plan sooner than its condition suggests. That is a planning consideration rather than a technical one, and it belongs in the commercial assessment alongside the test evidence rather than in place of it.

How Verification Is Expected to Be Evidenced

The evidence set describes accuracy, alarms and safety separately, and it identifies the consumables and configuration used. Without those last two items, a result may describe a device in a configuration the buyer will never use.

Where an accuracy measurement supports an acceptance decision, the traceability of the instrument producing it is what makes the result defensible, and the ILAC accreditation directory allows a provider’s status to be checked, with the principles described through the NIST measurement laboratory programmes. The servicing context these tests sit inside is covered by AAMI’s medical device servicing material, and independent guidance from organisations such as ECRI is a useful reference on the hazard patterns associated with infusion devices.

Where a batch of pumps is being accepted, the sequencing of the work matters as much as its content. Testing every unit takes time, and the time is wasted if the consumables required for testing are not available or if the configuration settings are not known in advance. Establishing the consumable type, obtaining the sets and confirming the required configuration before the batch arrives converts an open-ended acceptance exercise into a scheduled one, and it usually shortens the period during which the units are neither in service nor available for sale.

The commercial logic of buying used pumps in volume is usually about availability rather than price alone, and acceptance evidence is what protects that logic. A batch that is delivered quickly but cannot be brought into service for weeks has not delivered the availability that justified the purchase, and the delay is almost always traceable to a document that was not collected at the point of sale. Treating the verification records, the consumable details and the configuration requirements as part of the purchase specification rather than as follow-up work is what keeps a batch purchase from becoming a slow one.

Where the Framework Differs by Market

The requirement to verify infusion devices before use is expressed nationally and through the receiving organisation’s own systems, and the practical acceptance expectation is often set by the organisation rather than by an external rule. Two hospitals in the same market can require different evidence for the same pump, which is why the destination requirement should be established before purchase.

Where the obligation is framed as an employer duty, national workplace material such as the HSE health services guidance shows how one market expresses it. Where it attaches to the device, frameworks such as the MHRA guidance on regulating medical devices and the European Commission medical devices sector material apply, and cross-market expectations are summarised by the WHO medical devices programme. Where a device is supplied across a border, the acceptance requirement at the destination is what determines whether the file is complete.

What the Record Must Contain

The record has to allow a stranger to see what was tested, with what consumable and against which specification. Those three elements turn a result into evidence.

Common Misreadings and Overstatements

The assumptions below appear in pump purchases and in servicing records, and each of them allows an unverified function to be treated as verified.

• That an accuracy test verifies the pump. Accuracy and alarm behaviour fail independently, and a record covering one describes one.
• That a pump works with any set of the correct type. Accuracy depends on the consumable the device is calibrated for, and the specification is defined with reference to it.
• That a high usage count is only a maintenance consideration. Usage affects wear on mechanical components, and the device’s supported life affects whether maintenance remains economic.
• That configuration can be reset later without consequence. Configuration determines alarm limits and available settings, and inheriting an unknown configuration means accepting unknown behaviour until it is reviewed.
• That a recently serviced pump is ready for use. Service evidence describes a dated condition, and storage, transport and consumable changes all occur afterwards.

What a Buyer Should Ask For

The questions follow the structure of the device: what was tested, with what consumable, in what configuration, and what supports the measurement.

Ask which rates or volumes were tested and what the specification requires. Ask how occlusion and alarm behaviour were tested and what the outcomes were. Ask which consumable was used during testing and whether it matches the sets the buyer intends to use. Ask for the configuration and software version, and whether drug libraries or rate limits are department-specific. Ask for the service history, including usage counts, repairs and any indication that the device is approaching the end of its supported life. Ask for the electrical safety record and its date. Ask what the receiving organisation requires at acceptance, so remaining gaps can be closed before the units are delivered. Buyers who want the wider context can start from the knowledge hub, compare how equipment is described on the marketplace store, or use the cross-device verification material in the industry hub. Our analysis of how infusion pump calibration improves flow accuracy and nursing safety covers the operational context behind the same test evidence.